T
Telcare
Provides an FDA-cleared* meter connected to your care team, which keeps track of all your glucose readings
About Telcare
BioTelemetry, operating under the brand Telcare, is a pioneer in the mobile and wireless medical technology industry. The company specializes in delivering health information to improve patient outcomes and reduce healthcare costs. BioTelemetry's core offerings include cardiac and mobile blood glucose monitoring, centralized medical imaging, and original equipment manufacturing, primarily serving the healthcare and clinical research sectors. The company's flagship product, the Telcare Blood Glucose Monitoring System, was the first FDA-cleared cellular glucose meter and is now in its third generation. This system is complemented by an advanced online patient and provider portal, enhancing the continuum of care. BioTelemetry's business model revolves around the sale of its medical devices and associated services, generating revenue through direct sales to healthcare providers and patients. The company leverages wireless and cellular M2M (machine-to-machine) technology to connect patients with caregivers, ensuring seamless health management. BioTelemetry's market includes hospitals, clinics, and research institutions that require reliable and innovative medical monitoring solutions. The company's commitment to innovation and quality care positions it as a leader in the remote medical technology space.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2008
- Headquarters
- Bethesda, United States
- Employees
- 49
- Open positions
- None listed
- Dealroom signal
- 58.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Dec 2016 | $0 | — | BioTelemetry | — |
| SERIES COther financing | Oct 2014 | $33M | $130M | Qualcomm Ventures · Qualcomm · Mosaic Health Solutions · Sequoia | — |
Growth signals
Latest recorded traffic for Telcare is 300 monthly website visits, down 95.5% over the last three months. Telcare's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Qualcomm Ventures
Norwest Venture Partners
Mosaic Health Solutions
Other known investors1 additional known investor
BioTelemetry
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Telcare on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Telcare’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.